Epilepsy channelopathies go neddy: stabilizing Na_V1.1 channels by neddylation

Loss-of-function mutations of SCN1A encoding the pore-forming α subunit of the Na_V1.1 neuronal sodium channel cause a severe developmental epileptic encephalopathy, Dravet syndrome (DS). In this issue of the JCI, Chen, Luo, Gao, et al. describe a phenocopy for DS in mice deficient for posttranslational conjugation with neural precursor cell expressed, developmentally downregulated 8 (NEDD8) (neddylation), selectively engineered in inhibitory interneurons. Pursuing the possibility that this phenotype is also caused by loss of Na_V1.1, Chen, Luo, Gao, and colleagues show that interneuron excitability and GABA release are impaired, Na_V1.1 degradation rate is increased with a commensurate decrease of Na_V1.1 protein, and Na_V1.1 is a substrate for neddylation. These findings establish neddylation as a mechanism for stabilizing Na_V1.1 subunits and suggest another pathomechanism for epileptic sodium channelopathy.

Epilepsy is a disorder of brain function of which the cardinal feature is an enduring propensity for generating seizures. These anomalous paroxysms of hypersynchronous network activity may arise from a variety of brain insults, including developmental defects, acquired lesions (trauma, stroke, infection), and a myriad of associated gene defects. Mutations that disrupt ion channel genes, so-called channelopathies, are often identified in familial epilepsy syndromes or as de novo lesions in developmental epileptic encephalopathy.

Not surprisingly, epilepsy mutations often occur in genes coding for the pore-forming α subunits of voltage-gated sodium channels that generate action potentials in excitable cells (1–3). Mutant α subunits may have altered function or may fail to form a functional channel, and these discoveries have served as the foundation for understanding epileptogenesis at a molecular level. Accessory subunits of the channel complex and channel-interacting proteins have also emerged as culprits in epileptic channelopathies (4). In this issue of the JCI, Chen, Luo, Gao, et al. (5) report on uncovering a new potential mechanism for sodium-channel epilepsy, wherein disrupted neddylation of the channel α subunit increases the protein degradation rate and results in lower Na⁺ current density with reduced GABAergic inhibition by interneurons.

The human genome contains nine distinct α subunit genes (SCN1A, SCN2A, etc.) coding for the main pore-forming subunits Na_V1.1, Na_V1.2, etc. and four accessory β subunit genes (SCN1B, etc.). Epilepsy syndromes have been associated with mutations of Na_V1.1, Na_V1.2, Na_V1.3, Na_V1.6, and the β₁ subunit. The number of identified epilepsy mutations for Na_V1.1 greatly exceeds that for all the other sodium-channel subunits, and mutations of Na_V1.1 cause a wide variety of clinical phenotypes (Figure 1) ranging from mild to severe epilepsy with seizures refractory to drug treatment, developmental delay, and cognitive impairment (i.e., epileptic encephalopathy). A genotype/phenotype pattern is emerging wherein missense mutations of Na_V1.1 with modest alterations of channel function are found in mild syndromes (generalized epilepsy with febrile seizures [GEFS] and generalized epilepsy with febrile seizures plus [GEFS⁺]). In contrast, haploinsufficiency from a single null allele (e.g., frameshift, nonsense with premature truncation) causes a severe developmental epileptic encephalopathy with onset at six months of age (Dravet syndrome [DS]) (3). Over 700 pathogenic or likely pathogenic variants of SCN1A are listed for DS on ClinVar (https://www.ncbi.nlm.nih.gov/clinvar) as of March 2021.

Figure 1

Spectrum of epilepsy syndromes from Na_V1.1 loss of function. Na_V1.1 loss of function caused by SCN1A mutations or NEDD8 deficiency induces a wide variety of clinical phenotypes with varying severity.

The association of a severe epilepsy phenotype with a sodium-channel loss of function was initially puzzling because epilepsy is a disorder of anomalously enhanced excitability of neuronal activity. A major clue was provided by the Na_V1.1 knockout mouse (6). Global haploinsufficiency from heterozygous deletion of exon 26 (Scn1a^+/–) leads to early onset seizures (spontaneous and temperature induced), mild ataxia, and sudden unexplained death in epilepsy (SUDEP), which is similar to what occurs in individuals with DS. Na_V1.1-deficient mice had a reduction of Na⁺ current density and decreased firing rates of parvalbumin expressing inhibitory GABAergic neurons (PVINs), but not excitatory neurons, in the cerebral cortex, hippocampus, cerebellar Purkinje cells, and reticular nucleus of the thalamus. A similar epilepsy phenotype occurred with selective haploinsufficiency (PV-Scn1a^+/–) restricted to PV-positive interneurons, while the epilepsy phenotype was milder with Scn1a^+/– selective for somatostatin-positive inhibitory interneurons (7, 8). Conversely, haploinsufficiency of Scn1a in excitatory neurons ameliorates the DS phenotype (9). Exceptions to this genotype/phenotype paradigm indicate more work needs to be done. For example, about half of the SCN1A variants reported in DS cases are missense mutations, some of which caused gain-of-function changes in expression studies (10); the reduced excitability of PVINs in Scn1a^+/– mice at P14 later resolved at P18–P21, whereas seizures persisted (11). Others reported hyperexcitability and increased Na⁺ currents in P21–P24 hippocampal pyramidal neurons, suggesting overexpression of other sodium-channel genes (12). Nevertheless, the effects of murine Na_V1.1 loss of function coupled to severe early onset seizures and SUDEP are robust and were the basis for implicating Na_V1.1 in the neddylation studies by Chen, Luo, Gao, et al. reported in this issue (5).

Posttranslational modification by the ubiquitin-like protein neural precursor cell expressed, developmentally downregulated 8 (NEDD8) regulates many cellular functions (transcription, proliferation, differentiation, apoptosis), is essential for dendritic spine maturation and stability (13), and has been implicated in disorders of the central nervous system (14). To interrogate the role of NEDD8 in parvalbumin-positive inhibitory interneurons (PVINs), Chen, Luo, Gao, et al. (5) generated a conditional knockout of an obligatory subunit for the NEDD8-specific E1 (NAE1). Unexpectedly, the mice had severe epilepsy, ataxia, and a median survival of only 60 days. The abundance of PVINs was unchanged in PV-Nae1^–/– mice, but inhibitory GABAergic neurotransmission was reduced and intrinsic excitability was reduced for PVINs, but not pyramidal neurons. Further investigation for the cause of reduced excitability in PVINs revealed a Na⁺ current density of 62% of WT. When measured by immunoblot, Na_V1.1 protein amounts were decreased, whereas the abundance of the other major α subunit (Na_V1.6) remained unchanged. By comparison, Na⁺ current density for PVINs in the DS Scn1a^+/– mice was 47% of WT and 38% of WT for homozygous Scna1^–/– (6). Epileptic seizures began around P30 for PV-Nae1^–/– mice, whereas for DS Scna1^+/– mice, seizure onset was earlier (P21), consistent with a more severe loss of Na⁺ current for Scna1^+/–.

The observed reduction in Na⁺ current density is sufficient to explain the reduced excitability of PVINs, but why does impaired neddylation lead to lower amounts of Na_V1.1? There is no previously established role for regulating the abundance of voltage-gated ion channel proteins by neddylation, although for the epithelial sodium channel (α-ENaC), NEDD8 conjugated to cullin-1 increases ubiquitination and proteolytic degradation of the channel (15). Chen, Luo, Gao, and colleagues excluded a NEDD8 effect on Na_V1.1 transcript levels in PV-Nae1^–/– mice (5). Instead, expression studies in a human cell line (tsA-201 cells) showed an increased rate of proteasome-dependent Na_V1.1 degradation when neddylation was inhibited using MLN4924. The interpretation is that neddylation stabilizes Na_V1.1 by preventing ubiquitination, just the inverse of how NEDD8/cullin-1 regulates α-ENaC.

What is the evidence Na_V1.1 is a substrate for neddylation? NEDD8 immunoreactivity was detected after immunoprecipitation of tagged Na_V1.1 expressed in a human cell line (HEK cells) or for native Na_V1.1 from brain. Moreover, the NEDD8 signal was reduced in the presence of the NAE inhibitor MLN-4924 and for brain homogenates from PV-Nae1^–/– mice, consistent with neddylation of Na_V1.1. To search for potential neddylation sites at lysines in Na_V1.1, the authors screened for variants of Lys residues in ClinVar and an epilepsy database. Thirteen epilepsy variants were identified, two of which were studied further because they are located in cytoplasmic loops. The Na_V1.1 K1936E variant, 74 residues upstream from the C-terminal Lys, was expressed in HEK cells and found to have increased rates of Na_V1.1 degradation, reduced NEDD8 immunostaining, and lower Na⁺ current density, all of which are consistent with impaired neddylation and destabilized Na_V1.1 protein. Na_V1.1 K1936 is not conserved in Na_V1.6 (established using the multiple sequence alignment program CLUSTAL 1.2.4), which may account for the lack of a detectable change for Na_V1.6 expression in Nae1^–/– mice. Unfortunately, the clinical annotation for Na_V1.1 K1936E was insufficient to ascertain the confidence level showing that this is indeed a pathogenic mutation for epilepsy.

Many substrates for neddylation are surely present in PVINs, and the downstream effects of this posttranslational modification may be diverse and extensive. The authors acknowledge that effects beyond the reduction of Na_V1.1 may contribute to the ataxia and severe epilepsy in the PV-Nae1^–/– mouse. A proteome screen identified 5167 proteins with 169 downregulated and 279 upregulated for PV-Nae1^–/– mice compared with WT. The former group is implicated in neural development, synaptic plasticity, and glutamatergic neurotransmission, whereas the upregulated set is involved with ubiquitin-regulated catabolism and the metabolic pathway. Interestingly, of the 53 ion channel genes identified in this analysis, only the reduction of Na_V1.1 could readily account for the decreased excitability observed in PVINs.

The study by Chen, Luo, Gao, et al. in this issue of the JCI identifies a mechanism for fine-tuning neuronal excitability by neddylation-dependent stabilization of ion channel proteins and also reveals that selective disruption of this regulatory pathway in PVINs leads to ataxia, severe epilepsy, and SUDEP in mice (5). This phenotype highly resembles that of DS models in which the coding potential of Scn1a is destroyed and lends credence to the notion that loss-of-function defects for Na_V1.1 in PVINs produces susceptibility to severe epilepsy. It remains to be established that epilepsy in humans is attributable to impaired neddylation of Na_V1.1. One question is whether haploinsufficiency of Nae1 or some other critical component for NEDD8 conjugation will be sufficient to cause epilepsy. A global null of Nae1 is embryonic lethal (16). If neddylation is also deficient in excitatory pyramidal neurons, will the balance between excitation and inhibition be restored to ameliorate the risk of seizures as occurs in Scn1a^+/– mice (9)? Similarly, it is unknown whether a single Na_V1.1 K1936E allele is sufficient to cause an epilepsy phenotype in mice or humans. The probability of homozygous Na_V1.1 K1936E would be exceedingly small, except for cases of consanguinity. More studies in murine models may shed light on whether the heterozygous cases are sufficient to cause epilepsy.

SCC is supported by NIH grant R01 AR 063182 and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the UCLA Research Award Program.

Address correspondence to: Stephen Cannon, Department of Physiology, David Geffen School of Medicine, 10833 Le Conte Ave., Los Angeles, California 90095, USA. Phone: 310.825.5882; Email: sccannon@mednet.ucla.edu.

Conflict of interest: The author has declared that no conflict of interest exists.

Copyright: © 2021, American Society for Clinical Investigation.

Reference information: J Clin Invest. 2021;131(8):e148370. https://doi.org/10.1172/JCI148370.

See the related article at Neddylation stabilizes Na_v1.1 to maintain interneuron excitability and prevent seizures in murine epilepsy models.

1. Mantegazza M, et al. Sodium channelopathies of skeletal muscle and brain. [published online March 26, 2021]. Physiol Rev. https://doi.org/10.1152/physrev.00025.2020.
   View this article via: PubMed Google Scholar
2. Escayg A, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet. 2000;24(4):343–345.
   View this article via: PubMed CrossRef Google Scholar
3. Claes L, et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet. 2001;68(6):1327–1332.
   View this article via: PubMed CrossRef Google Scholar
4. Wallace RH, et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet. 1998;19(4):366–370.
   View this article via: PubMed CrossRef Google Scholar
5. Chen W, et al. Neddylation stabilizes Na_v1.1 to maintain interneuron excitability and prevent seizures in murine epilepsy models. J Clin Invest. 2021;131(8):e136956.
   View this article via: JCI PubMed CrossRef Google Scholar
6. Yu FH, et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci. 2006;9(9):1142–1149.
   View this article via: PubMed CrossRef Google Scholar
7. Cheah CS, et al. Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome. Proc Natl Acad Sci U S A. 2012;109(36):14646–14651.
   View this article via: PubMed CrossRef Google Scholar
8. Rubinstein M, et al. Dissecting the phenotypes of Dravet syndrome by gene deletion. Brain. 2015;138(Pt 8):2219–2233.
   View this article via: PubMed Google Scholar
9. Ogiwara I, et al. Nav1.1 haploinsufficiency in excitatory neurons ameliorates seizure-associated sudden death in a mouse model of Dravet syndrome. Hum Mol Genet. 2013;22(23):4784–4804.
   View this article via: PubMed CrossRef Google Scholar
10. Rhodes TH, et al. Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy. Proc Natl Acad Sci U S A. 2004;101(30):11147–11152.
    View this article via: PubMed CrossRef Google Scholar
11. Favero M, et al. A transient developmental window of fast-spiking interneuron dysfunction in a mouse model of Dravet syndrome. J Neurosci. 2018;38(36):7912–7927.
    View this article via: PubMed CrossRef Google Scholar
12. Mistry AM, et al. Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice. Neurobiol Dis. 2014;65:1–11.
    View this article via: PubMed CrossRef Google Scholar
13. Vogl AM, et al. Neddylation inhibition impairs spine development, destabilizes synapses and deteriorates cognition. Nat Neurosci. 2015;18(2):239–251.
    View this article via: PubMed CrossRef Google Scholar
14. Mori F, et al. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders. Neuropathol Appl Neurobiol. 2005;31(1):53–61.
    View this article via: PubMed CrossRef Google Scholar
15. Downs CA, et al. H2O2 regulates lung epithelial sodium channel (ENaC) via ubiquitin-like protein Nedd8. J Biol Chem. 2013;288(12):8136–8145.
    View this article via: PubMed CrossRef Google Scholar
16. Zou J, et al. Neddylation mediates ventricular chamber maturation through repression of Hippo signaling. Proc Natl Acad Sci U S A. 2018;115(17):E4101–E4110.
    View this article via: PubMed CrossRef Google Scholar